Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Anthony @ Equity Investigations, Dear Anthony, -- Ignore unavailable to you. Want to Upgrade?

To: majormember who wrote (49442)	1/12/2000 12:25:00 PM
From: Anthony@Pacific	Read Replies (1) \| Respond to of 122087

COOOL reasoning ..so lets all assume SNRS wil get approval for the reading gklass Mkt on a product that they canot sell anywher even Europe

To: majormember who wrote (49442)	1/12/2000 12:52:00 PM
From: Kevin Podsiadlik	Read Replies (1) \| Respond to of 122087

1. Lehman put "Buy" rating Dec. 13th Read that VUSA article for what we think of analyst recs these days. 2. Lehman pumps 11.7 Mil on Jan. 11th Not Lehman themselves but a subsidiary. Could have been the prelude to a nearly riskless short. 3. The two most antaganistic panel members won't be on this panel. Just remember, all the other panelists agreed with them. 4. My M.D., Eve H., voting panel member, wouldn't tell me her vote (of course). I surmised it would be yes. Yeah that sure follows. 5. Hopkins/Wilmer is sending Dr. Stark as a non-voting panel member. He is a Big Gun and pro-SNRS. Didn't they have someone on the first panel? 6. Ultimately, the bar for approval has been lowered As I said, that means the stock could tank even on approval and the FDA who scheduled this would not want a rejection. Where did this notion come from that the FDA wants their panels to be rubber stamps? "that-that's about all folks" (bugs bunny) When did Bugs get a stutter?